Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| DGX | Davis J. E. | CEO and President | 09/01/2026 | Verkauf | 242.72 | 10,000 | 2,427,200 | Form 4 |
| DGX | Prevoznik Michael E | SVP & General Counsel | 08/28/2026 | Schenkung | — | 1,000 | — | Form 4 |
| DGX | Prevoznik Michael E | SVP & General Counsel | 08/28/2026 | Verkauf | 244.51 | 430 | 105,141 | Form 4 |
| DGX | Prevoznik Michael E | SVP & General Counsel | 08/28/2026 | Verkauf | 243.63 | 6,237 | 1,519,505 | Form 4 |
| DGX | Prevoznik Michael E | SVP & General Counsel | 08/28/2026 | Verkauf | 242.88 | 16,010 | 3,888,437 | Form 4 |
| DGX | Prevoznik Michael E | SVP & General Counsel | 08/28/2026 | Optionsausübung | 112.17 | 22,677 | 2,543,679 | Form 4 |
| DGXX | Amar Alec | President | 08/20/2026 | Kauf | 3.86 | 10,000 | 38,600 | Form 4 |
| DGXX | Amar Michel | Chief Executive Officer | 08/19/2026 | Kauf | 3.60 | 20,000 | 72,000 | Form 4 |
| DGX | Delaney Mark E | SVP & Chief Commercial Officer | 07/28/2026 | Verkauf | 235.18 | 1,600 | 376,288 | Form 4 |
| DGX | Kuppusamy Karthik | SVP, Clinical Solutions | 07/22/2026 | L | 206.81 | 37 | 7,652 | Form 4 |
| DGX | Carter Robert B | Director | 07/22/2026 | L | 206.80 | 11 | 2,275 | Form 4 |
| DGX | Gregg Vicky B | Director | 07/22/2026 | Zuteilung | 206.81 | 72 | 14,890 | Form 4 |
| DGX | Plewman Patrick | SVP for Diagnostic Services | 07/22/2026 | L | 206.81 | 46 | 9,513 | Form 4 |
| DGX | Main Timothy L | Director | 07/22/2026 | L | 206.81 | 21 | 4,343 | Form 4 |
| DGX | Samad Sam | Executive Vice President & CFO | 07/22/2026 | Zuteilung | 206.81 | 102 | 21,094 | Form 4 |
| DGX | Lassiter Wright III | Director | 07/22/2026 | L | 206.81 | 6 | 1,241 | Form 4 |
| DGX | Delaney Mark E | SVP & Chief Commercial Officer | 07/22/2026 | L | 206.81 | 34 | 7,031 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).